Fundraising Fox

Biotech Investors & VC Firms in Europe

204 firms in this list, with a median first check of $540K. 19 of them lead rounds. Generated from verified public data and updated continuously.

Innovestor Ventures
HelsinkiPre-Seed–Growth$270K – $3.2M
28 people
RA Capital
BostonSeed–Late Stage
11 people
GV (Google Ventures)
Mountain ViewSeed–Late Stage
34 people
Joyance Partners
Pre-Seed–Series A
35 people
Anzu Partners
TampaPre-Seed–Growth
42 people
Sofinnova Partners
ParisPre-Seed–Late Stage$540K – $27M
11 people
Giant Ventures Global Llp
LondonPre-Seed–Late Stage
30 people
Advent Life Sciences
LondonSeed–Late Stage
25 people
Octopus Ventures
LondonPre-Seed–Late Stage$125K – $31.8M
27 people
LSP (Life Sciences Partners)
StockholmSeries A–Late Stage$10M – $60M
42 people
Mission Biocapital
San FranciscoPre-Seed–Seed$500K – $500K
20 people
Polaris Partners
BostonSeed–Growth$500K – $5M
31 people
Apple Tree Venture Management Llc
New YorkPre-Seed–Late Stage
20 people
Oxford Science Enterprises
OxfordPre-Seed–Growth$63.5K – $31.8M
11 people
Abingworth
LondonPre-Seed–Late Stage$15M – $30M
35 people
Medicxi
LondonPre-Seed–Late Stage
34 people
Faber
LisbonPre-Seed–Series A$2.8M
17 people
Versant Ventures
San FranciscoSeed–Late Stage$250K – $5M
36 people
Novartis Venture Fund
BaselPre-Seed–Late Stage$5M – $25M
22 people
IQ Capital
CambridgePre-Seed–Series B$1M – $40M
11 people
Kurma Partners
ParisPre-Seed–Series B$162K – $10.8M
11 people
M Ventures
Los AngelesSeed–Series A$10.8M
11 people
Essex Woodlands Healthcare Partners
New YorkGrowth–Late Stage$20M – $80M
18 people
Flagship Pioneering
CambridgeSeed–Series A$500K – $10M
11 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.